Feature

What’s Driving the Higher Breast Cancer Death Rate in Black Women?


 

Hope for Improved Outcomes, Higher Survival Rates

Investigators hope the findings of all of this new research lead to better, more targeted treatments and, in turn, improved outcomes.

Dr. Haricharan is optimistic about the improvement of breast cancer outcomes as more is learned about the biology of Black patients and other non-White patients.

There is a growing effort to include more data from minoritized populations in breast cancer research studies, Dr. Haricharan said, and she foresees associated changes to clinical protocols in the future. Her own team is working on creating larger data sets that are more representative of non-White patients to further analyze the differences found in their prior study.

“I think there’s this understanding that, until we have data sets that are more representative, we really are catering to [only one] population in terms of our diagnostic and therapeutic technological advances,” she said.

The American Cancer Society meanwhile, is launching a new initiative in May that aims to collect more health data from Black women to ultimately develop more effective cancer interventions. VOICES of Black Women will focus on collecting and studying health data from Black women through online surveys. The society’s goal is to enroll at least 100,000 Black women in the United States between ages 25 and 55.

Dr. Miller-Kleinhenz called the initiative “an important step to starting to research and answer some of these lingering questions about why there continue to be breast cancer disparities.”

Pages

Recommended Reading

Active Surveillance for Cancer Doesn’t Increase Malpractice Risk
Federal Practitioner
A Banned Chemical That Is Still Causing Cancer
Federal Practitioner
Should Opioids Be Used for Chronic Cancer Pain?
Federal Practitioner
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Federal Practitioner
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Federal Practitioner
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Federal Practitioner
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Federal Practitioner
No Routine Cancer Screening Option? New MCED Tests May Help
Federal Practitioner
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Federal Practitioner
Certain Women May Face Higher Risk for Second Breast Cancer
Federal Practitioner